JP2018521077A5 - - Google Patents

Download PDF

Info

Publication number
JP2018521077A5
JP2018521077A5 JP2018503204A JP2018503204A JP2018521077A5 JP 2018521077 A5 JP2018521077 A5 JP 2018521077A5 JP 2018503204 A JP2018503204 A JP 2018503204A JP 2018503204 A JP2018503204 A JP 2018503204A JP 2018521077 A5 JP2018521077 A5 JP 2018521077A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pharmaceutically acceptable
pde4
phosphodiesterase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018503204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018521077A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/067968 external-priority patent/WO2017017165A1/en
Publication of JP2018521077A publication Critical patent/JP2018521077A/ja
Publication of JP2018521077A5 publication Critical patent/JP2018521077A5/ja
Pending legal-status Critical Current

Links

JP2018503204A 2015-07-29 2016-07-28 糖尿病性腎症を治療するためのｐｄｅ４阻害剤 Pending JP2018521077A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562198213P 2015-07-29 2015-07-29
US62/198,213 2015-07-29
PCT/EP2016/067968 WO2017017165A1 (en) 2015-07-29 2016-07-28 Pde4 inhibitor for the treatment of diabetic nephropathy

Publications (2)

Publication Number Publication Date
JP2018521077A JP2018521077A (ja) 2018-08-02
JP2018521077A5 true JP2018521077A5 (https=) 2019-09-05

Family

ID=56551407

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503204A Pending JP2018521077A (ja) 2015-07-29 2016-07-28 糖尿病性腎症を治療するためのｐｄｅ４阻害剤

Country Status (9)

Country Link
US (1) US20200179369A1 (https=)
EP (1) EP3328381A1 (https=)
JP (1) JP2018521077A (https=)
CN (1) CN108135886A (https=)
BR (1) BR112018001116A2 (https=)
CA (1) CA2992796A1 (https=)
EA (1) EA201890346A1 (https=)
MA (1) MA42519A (https=)
WO (1) WO2017017165A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110099686B (zh) * 2016-08-26 2022-04-15 武田药品工业株式会社 非酒精性脂肪性肝病的治疗
CN116637115A (zh) * 2017-05-27 2023-08-25 广州喜鹊医药有限公司 川芎嗪硝酮衍生物组合物在预防和治疗糖尿病并发症疾病中的应用
CN114053281B (zh) * 2020-08-10 2025-05-27 成都文鼎科技发展有限公司 治疗慢性肾病的方法和药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508358A (ja) * 2001-10-25 2005-03-31 デポメド・インコーポレイテッド 胃滞留型ロサルタン投与量を用いる治療方法
US7157584B2 (en) * 2004-02-25 2007-01-02 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
CN104803974A (zh) * 2004-03-03 2015-07-29 塔科达有限责任公司 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
GB0504103D0 (en) * 2005-02-28 2005-04-06 Syngenta Ltd Novel method

Similar Documents

Publication Publication Date Title
EA201000702A1 (ru) Некоторые производные 2-пиразинона и их применение в качестве ингибиторов нейтрофильной эластазы
JP2013535487A5 (https=)
JP2021509912A5 (https=)
JP2017518334A5 (https=)
EA201100613A1 (ru) Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций
JP2014505107A5 (https=)
JP2010265321A5 (https=)
JP2013510124A5 (https=)
JP2011522816A5 (https=)
JP2011502958A5 (https=)
JP2010222367A5 (https=)
JP2010530376A5 (https=)
JP2012507535A5 (https=)
JP2020536919A5 (https=)
JP2017517538A5 (https=)
JP2009538861A5 (https=)
JP2016512817A5 (https=)
JP2015526455A5 (https=)
JP2018521077A5 (https=)
JP2017509611A5 (https=)
JP2011515406A5 (https=)
JP2009518415A5 (https=)
JP2016512541A5 (https=)
JP2012520302A5 (https=)
JP2012523416A5 (https=)